Biodexa Pharmaceuticals Plc (BDRX)
NASDAQ: BDRX · Real-Time Price · USD
3.710
-0.090 (-2.37%)
Feb 21, 2025, 4:00 PM EST - Market closed
Biodexa Pharmaceuticals Employees
Biodexa Pharmaceuticals had 21 employees as of December 31, 2023. The number of employees decreased by 6 or -22.22% compared to the previous year.
Employees
21
Change (1Y)
-6
Growth (1Y)
-22.22%
Revenue / Employee
$4,995
Profits / Employee
-$410,371
Market Cap
2.15M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 440,000 |
| Johnson & Johnson | 131,900 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 72,000 |
BDRX News
- 9 days ago - Biodexa Pharmaceuticals PLC to Present at the Emerging Growth Conference on February 19, 2025 - GlobeNewsWire
- 10 days ago - Following Positive Phase 2 Results and Orphan Drug Designation, Biodexa's FAP Drug Receives FDA Fast Track Status - Accesswire
- 12 days ago - Biodexa Receives US FDA Fast Track Designation for eRapa in Familial Adenomatous Polyposis - GlobeNewsWire
- 4 weeks ago - Biodexa Strengthens Management Team - Appointment of Dr Gary A. Shangold as Chief Medical Officer - GlobeNewsWire
- 3 months ago - Result of General Meeting - GlobeNewsWire
- 3 months ago - Gaining Momentum, Biodexa is Advancing Two Recent Acquisitions Through the Clinic - Accesswire
- 3 months ago - Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) Regains Compliance For Continued Listing on Nasdaq - GlobeNewsWire
- 3 months ago - Notice of General Meeting - GlobeNewsWire